NCT06761092

Brief Summary

Analyzing the effectiveness of nebulized dexmedetomidine 2 mcg/kg in reducing the incidence of post-anesthesia delirium in preschool children undergoing elective surgery with sevoflurane inhalation general anesthesia. Researchers will compare nebulized Dexmedetomidine to a placebo (a look-alike substance that contains no drug) to see if the drug can reduce post anesthesia delirium incidence.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Dec 2024

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 13, 2024

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

December 29, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 7, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 7, 2025

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 13, 2025

Completed
Last Updated

January 22, 2025

Status Verified

December 1, 2024

Enrollment Period

2 months

First QC Date

December 29, 2024

Last Update Submit

January 18, 2025

Conditions

Keywords

nebulizeddexmedetomidinepost anesthesia deliriumsevofluranepreschool

Outcome Measures

Primary Outcomes (1)

  • reduce post anesthesia delirium incidence

    After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the PAED score at 15, 30, 60, and 120 minutes post-surgery in the recovery room.

    120 minutes (after extubation till discharge from recovery room)

Study Arms (2)

Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children

ACTIVE COMPARATOR

Nebulization with the anesthetic drug dexmedetomidine at a dose of 2 mcg/kg body weight, diluted to 3 ml with 0.9% normal saline, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the pediatric anesthesia emergence delirium score (PAED score) at 15, 30, 60, and 120 minutes post-surgery in the recovery room.

Drug: Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children

Nebulized Normal Saline 0.9% for Post-Anesthesia Delirium in Preschool Children

PLACEBO COMPARATOR

Nebulization with normal saline 0.9% 3ml, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the pediatric anesthesia emergence delirium score (PAED score) at 15, 30, 60, and 120 minutes post-surgery in the recovery room.

Procedure: Nebulized 0.9% Normal Saline

Interventions

Nebulization with the anesthetic drug dexmedetomidine at a dose of 2 mcg/kg body weight, diluted to 3 ml with 0.9% normal saline, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the PAED score at 15, 30, 60, and 120 minutes post-surgery in the recovery room

Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children

Nebulization with normal saline 0.9% 3 ml, administered before the induction of anesthesia in the reception area. After the anesthesia, primary data collection is conducted by recovery room staff who are blinded to the treatment and control groups. Data includes scores or levels of post-anesthesia delirium or agitation assessed using the PAED score at 15, 30, 60, and 120 minutes post-surgery in the recovery room

Nebulized Normal Saline 0.9% for Post-Anesthesia Delirium in Preschool Children

Eligibility Criteria

Age2 Years - 6 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Pediatric patients aged 2 to 6 years old.
  • Planned general anesthesia using inhalation sevoflurane with endotracheal tube techniques
  • Parents agree to participate in the study

You may not qualify if:

  • Pediatric patients with \> ASA II.
  • Difficult airway management.
  • Emergency surgery.
  • Congenital abnormalities of vital organs.
  • Malnutrition
  • history or diagnosed with mental or cognitive disorders.
  • History of upper respiratory infection within 2 weeks before the procedure.
  • History of allergy to dexmedetomidine.
  • Surgery duration estimation exceeding 180 minutes.
  • Parents refuse to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anesthesiology and Intensive Therapy Udayana University

Denpasar, Bali, Indonesia

Location

MeSH Terms

Conditions

Emergence Delirium

Interventions

Saline Solution

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: pediatric preschool, age 2-6 years old, undergoing elective general surgery
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

December 29, 2024

First Posted

January 7, 2025

Study Start

December 13, 2024

Primary Completion

February 7, 2025

Study Completion

February 13, 2025

Last Updated

January 22, 2025

Record last verified: 2024-12

Locations